Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is somatic RET mutation a prognostic factor for sporadic medullary thyroid carcinoma?

Nature Clinical Practice Endocrinology & Metabolism volume 4, pages 432–433 (2008)Cite this article

boxed-textElisei R et al. (2008) Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J Clin Endocrinol Metab 93: 682–687

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Moley JF and Fialkowski EA (2007) Evidence-based approach to the management of sporadic medullary thyroid carcinoma. World J Surg 31: 946–956

    Article  Google Scholar 

  2. Lakhani VT et al. (2007) The multiple endocrine neoplasia syndromes. Annu Rev Med 58: 253–265

    Article  CAS  Google Scholar 

  3. de Groot JW et al. (2006) RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors. Endocr Rev 27: 535–560

    Article  CAS  Google Scholar 

  4. Schlumberger M et al. (2008) New therapeutic approaches to treat medullary thyroid carcinoma. Nat Clin Pract Endocrinol. Metab 4: 22–32

    Article  CAS  Google Scholar 

  5. Rubin BP et al. (2007) Gastrointestinal stromal tumour. Lancet 369: 1731–1741

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Department of Molecular Medicine and Surgery, Karolinska University, Hospital, SE-171 76 Stockholm, Sweden jan.zedenius@ki.se

Authors and Affiliations

  1. J Zedenius is Chief of Endocrine Surgery at the Karolinska University Hospital, Stockholm, Sweden.,

    Jan Zedenius

Authors
  1. Jan Zedenius
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zedenius, J. Is somatic RET mutation a prognostic factor for sporadic medullary thyroid carcinoma?. Nat Rev Endocrinol 4, 432–433 (2008). https://doi.org/10.1038/ncpendmet0866

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0866

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing